TransMedics Grants 40,089 Options at $135.50 and 26,549 RSUs to 14 Hires
On February 18, 2026, TransMedics granted 40,089 non-qualified stock options at a $135.50 exercise price and 26,549 restricted stock units to 14 new employees as inducements. The CCO Giovanni Cecere received 16,734 options and 11,082 RSUs, with vesting over four years under the Inducement Plan.
1. Inducement Grants Overview
On February 18, 2026, TransMedics granted an aggregate of 40,089 non-qualified stock options and 26,549 restricted stock units to 14 new employees under its Inducement Plan, including 16,734 options and 11,082 RSUs awarded to Chief Commercial Officer Giovanni Cecere.
2. Approval and Pricing
The Compensation Committee approved the grants under Nasdaq Listing Rule 5635(c)(4), setting the option exercise price at $135.50, equal to the closing share price on the grant date.
3. Vesting Schedule and Terms
Options vest 25% after one year and monthly thereafter over three years, with a 10-year term, while restricted stock units vest 25% on each of the first four anniversaries, all contingent on continued service.